Is UFP Technologies (UFPT) Pricing Reflect A Temporary Pullback Or Longer Term Opportunity

• If you are wondering whether UFP Technologies at around US$215.67 reflects too much optimism or still leaves room for upside, this article will help you understand what you are really paying for.
• The stock has recently seen a 3.2% decline over the last 7 days and a 14.3% decline over the last 30 days, while the 3 year return of 80.8% and a very large 5 year return highlight how different holding periods can feel very different for investors.
• Recent coverage of UFP Technologies has focused on it as a specialized healthcare materials and packaging business, which helps explain why the stock can react sharply when investor expectations around procedure volumes or product demand change. This context is important when considering whether the recent 7% 1 year return decline is a temporary pause or indicates a change in how the market views the company.
• On our framework, UFP Technologies currently scores a 4 out of 6 valuation checks, which means it appears undervalued on four measures and less compelling on two. Next, we will walk through these valuation approaches in detail and then finish with a more complete way to think about what the stock might be worth.

UFP Technologies delivered -7.0% returns over the last year. See how this stacks up to the rest of the Medical Equipment industry.

Approach 1: UFP Technologies Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model takes the cash UFP Technologies is expected to generate in the future and discounts it back to what those dollars might be worth to you today.

For UFP Technologies, the model uses last twelve months free cash flow of about $86.7 million and a 2 Stage Free Cash Flow to Equity approach, where the first stage relies on analyst projections and the second stage extends those estimates further out. Simply Wall St uses analyst input for the early years, then extrapolates beyond that. By 2035, the ten year projection in this model points to free cash flow of about $161.8 million, all expressed in $.

Adding up these discounted cash flows, the model arrives at an estimated intrinsic value of roughly $335.81 per share. Against the current share price of about $215.67, this implies the stock trades at a 35.8% discount, which suggests the market price is materially below what this DCF model indicates the business may be worth.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests UFP Technologies is undervalued by 35.8%. Track this in your watchlist or portfolio, or discover 54 more high quality undervalued stocks.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for UFP Technologies.

Approach 2: UFP Technologies Price vs Earnings

For a profitable company like UFP Technologies, the P/E ratio is a useful way to relate what you pay per share to the earnings the business is currently generating. Investors usually accept a higher P/E when they expect stronger earnings growth or see lower risk, and a lower P/E when they see slower growth or higher risk.

UFP Technologies currently trades on a P/E of about 24.3x. That compares with the Medical Equipment industry average P/E of around 30.9x and a peer average of about 33.1x, so the stock is priced below both of those reference points. Simply Wall St also calculates a “Fair Ratio” for the company of 19.8x, which reflects the P/E level suggested by factors such as its earnings growth profile, industry, profit margins, market cap and risk characteristics.

This Fair Ratio is designed to be more tailored than a simple comparison with peers or the industry because it incorporates company specific fundamentals instead of assuming one size fits all. On this framework, UFP Technologies’ current P/E of 24.3x sits above the Fair Ratio of 19.8x, which indicates that the shares are trading on a richer multiple than this model suggests.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your UFP Technologies Narrative

Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives, which are simply your own story about UFP Technologies tied to your assumptions for future revenue, earnings and margins, and then translated into a Fair Value you can compare with the current share price.

On Simply Wall St’s Community page, Narratives make this easy by linking what you believe about the business to a full forecast and Fair Value, updating automatically when new earnings or news arrive so your view does not go stale.

For UFP Technologies, one investor might lean toward the higher Fair Value of US$370.00, focusing on factors like MedTech exposure and efficiency gains, while another might anchor on the lower Fair Value of US$289.00, giving more weight to customer concentration and operational risks. Narratives then help you see exactly how each view leads to a different Fair Value and what that means relative to today’s price.

Do you think there's more to the story for UFP Technologies? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com